DOD Funds Study of Link between Diabetes and Breast Cancer
Researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have received a three-year, $1.5 million grant to study a protein known as RAGE — an acronym for Receptor for Advanced Glycation End-products — that may be a link between diabetes and breast cancer.
Miller School Study Shows Risk Factors on the Rise Among People with Stroke
Despite prevention efforts, researchers at the University of Miami Miller School of Medicine have found a significant increase over a 10-year period in the percentage of people with stroke who have high blood pressure, diabetes, smoking and other risk factors for stroke. The study is published in the October 11 online issue of Neurology®, the medical journal of the American Academy of Neurology.
Gene Therapy Provides Pain Relief Equivalent to Morphine in Study
In a new study published in NeuroReport, senior author Roy C. Levitt, MD, lead author Eugene S. Fu, MD, and their colleagues of the University of Miami Miller School of Medicine Department of Anesthesiology, Perioperative Medicine and Pain Management, showed delivering a key regulatory gene using an adeno-associated viral (AAV) vector could provide prolonged and profound analgesia in mice.
Dr. Hansel Tookes Named a National ‘Upstander’ for Lifesaving Needle Exchange
Hansel Tookes, M.D., MPH, assistant professor of medicine in the Division of Infectious Diseases at the University of Miami Miller School of Medicine, has been named one of 11 national “Upstanders” by Starbucks and is featured in a video that was screened in New York Monday night. The video tells the story of Tookes’ multi-year campaign to save lives through the Infectious Disease Elimination Act (IDEA) in Florida.
Miller School Study Points to Innovative Epigenetic Strategy for Alzheimer’s Disease
A University of Miami Miller School of Medicine research team has identified an innovative epigenetic strategy using a single molecule to turn off multiple genes that drive Alzheimer’s disease. The researchers demonstrated that an epigenetic molecule called M344 penetrates the brain, targets the buildup of beta-amyloid peptides associated with Alzheimer’s disease, increases neuroprotective genes and increases memory.